FDA Study Finds Geography Not A Good Predictor Of Quality for Hard-To- Make Drugs
Executive Summary
An FDA study asserts that where a drug is made is not necessarily a good indicator of its quality, and that for some hard-to-make drugs, the same manufacturing problems affect drugs in the US as in other parts of the world.